Awards

BrainScope Nominated for the 2017 11th Annual Prix Galien USA Award for Best Medical Technology Product

NEW YORK, July 26, 2017 /PRNewswire/ -- The Galien Foundation announced today the 2017 11th Annual Prix Galien USAAward Nominees. Counted among the global health innovation industry's most prized honors, the Prix Galien Award recognizes outstanding biomedical and technology product achievement that improves the human condition.

To qualify, each candidate must be U.S. Food and Drug Administration (FDA) approved for market within the last five years and demonstrate tremendous potential to impact human health. Sales data are not considered by the nominating committee in their award nominee selection; only science and health impact.

Source

BrainScope Receives Frost & Sullivan Best Practices Award in Traumatic Brain Injury Assessment

BETHESDA, MD. July 10, 2017 – BrainScope Company, Inc. today announced that it has received the Frost & Sullivan 2017 Best Practices Award for New Product Innovation in the Traumatic Brain Injury Assessment Solutions Market.

“A pioneer in quantitative TBI assessment, Brainscope is poised for rapid and expansive growth. Frost & Sullivan firmly believes that BrainScope is set to become the respected and recognized clinical standard for mild head injury assessment,” stated Patrick Riley, Principal Analyst at Frost & Sullivan. The full write up of the award can be found here.

Frost & Sullivan has 50 years of experience researching technical and economic trends and best practices to provide clients with a complete picture of their position within an industry. As part of this ongoing research, Frost & Sullivan identifies companies that have successfully introduced new and innovative products into their markets, with emphasis on product quality and customer value. This process involves extensive primary and secondary research across the entire value chain of specific products. The 2017 New Product Innovation Award for Product Innovation in the Traumatic Brain Injury Assessment Solutions Market compared top manufacturers in three key areas: understanding demand, nurturing the brand, and differentiating from the competition. BrainScope received top marks in all areas of the research. 

“We are honored to be recognized by Frost & Sullivan, whose analysts closely track our industry. We greatly appreciate the recognition for our innovation in developing and introducing our FDA-cleared product, BrainScope One, which addresses the very significant need for objective and comprehensive brain injury assessment,” stated Michael Singer, CEO of BrainScope.

GE AND THE NFL AWARD BRAINSCOPE WITH FURTHER FUNDING

BETHESDA, MD. July 23, 2015 – BrainScope Company, Inc. today announced that it has received an additional $500,000 award from GE and the National Football League (NFL) to further enhance its portable concussion assessment system, as one of six final winners of the GE NFL Head Health Challenge I. In February 2014, Brainscope was selected as one of the initial 16 recipients from more than 400 entries from 27 countries of the up to $10 million Challenge, which was created by GE and the NFL to award entrants for proposals focusing on “identifying breakthrough technologies and approaches that will improve the diagnosis and prognosis of mild traumatic brain injury (TBI).”

BRAINSCOPE AWARDED OVER $15.9 MILLION IN DEPARTMENT OF DEFENSE RESEARCH CONTRACTS

BETHESDA, MD. September 30, 2014 – BrainScope® Company, Inc. today announced that it has been awarded three contracts by the United States Department of Defense (DOD), both from the U.S. Army and Navy, for continued research and development of its Ahead® system for the assessment of Traumatic Brain Injury (TBI) and concussion. These three contracts combined are valued at $15.93 million. These newly awarded contracts will enable BrainScope to conduct further clinical studies and development of its TBI and concussion technology in hospital Emergency Departments and with university sports programs. From 2011 through 2013, BrainScope was awarded $11.27 million of DOD research contracts for the development of its TBI assessment technology, bringing the total awarded to date to $27.2 million. In addition, BrainScope has received significant funding from private investors to accelerate its development efforts.

BrainScope Receives GE NFL Head Health Challenge I Award

BETHESDA, MD. January 23rd, 2014 – BrainScope® Company, Inc. today announced that it has received an award from the GE and the National Football League (NFL) to further enhance its portable concussion assessment system by combining imaging biomarkers with its brainwave technology. In 2013, GE and the NFL created the $10 million Head Health Challenge I competition to award entrants for proposals focusing on “identifying breakthrough technologies and approaches that will improve the diagnosis and prognosis of mild traumatic brain injury (TBI).” The sixteen recipients of the award, including BrainScope, were announced today in New York.

BrainScope Awarded Montgomery County Emerging Business of the Year

BETHESDA, MD. December 6th, 2012 – BrainScope® Company, Inc. announced today that it received the Verl Zanders Emerging Business of the Year Award by the Montgomery County Chamber of Commerce (MCCC) last evening at the 2012 MCCC Business Awards Dinner & Reception. The event was attended by over 700 business and government leaders. Among the seven awards presented during the evening were esteemed recipients such as J.W. Marriott, Jr. (Emeritus Business Leader), Booz Allen Hamilton (Prime Partner of the Year), and Lockheed Martin (Corporate Achievement).